Endothelin receptor mediated constriction and dilatation in feline cerebral resistance arterioles in vivo

European Journal of Pharmacology

Volumn 307, Issue 1, 1996, Pages 41-48

  Patel, Toshal R ^a   McAuley, Moira A ^a   McCulloch, James ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

BQ 123; BQ 3020; Cerebral circulation; Endothelin receptor; Endothelin 1; Resistance arteriole, cerebral

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN RECEPTOR; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE];

ADVENTITIA; ANIMAL EXPERIMENT; ARTERIOLE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BRAIN CIRCULATION; CAT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; TOPICAL DRUG ADMINISTRATION;

EID: 0030594570     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00188-4     Document Type: Article

References (54)

1. Adner, M., J. You and L. Edvinsson, 1993, Characterisation of endothelin-A receptors in the cerebral circulation, Neuroreport 4, 441.
2. Arai, H., S. Hori, I. Aramori, H. Ohkubo and S. Nakanishi, 1990, Cloning and expression of a cDNA encoding an endothelin receptor, Nature 348, 730.
3. Armstead, W. M., R. Mirro, C. W. Leffler and D. W. Busija, 1989, Influence of endothelin on piglet cerebral microcirculation, Am. J. Physiol. 257, H707.
4. Baez, S., 1966, Recording of microvascular dimensions with an image splitter television microscope, J. Appl. Physiol. 21, 299.
5. Barone, F.C., M.Y.-T. Globus, W.J. Price, R.F. White, B.L. Storer, G.Z. Feuerstein, R. Busto and E.H. Ohlstein, 1993, Endothelin levels increase in rat focal and global ischaemia, J. Cereb. Blood Flow Metab. 14, 337.
6. Bian, L.G., T.X. Zhang, W.G. Zhao, J.K. Shen and G.Y. Yang, 1994, Increased endothelin-1 in the rabbit model of middle cerebral artery occlusion, Neurosci. Lett. 174, 47.
7. B receptor mediates vasodilatation and vasoconstriction in vivo, Biochem. Biophys. Res. Commun. 186, 867.
8. Clozel, M., V. Breu, K. Burri, J.-M. Cassal, W. Fischli, G.A. Gray, G. Hirth, B-M. Loffler, M. Muller, W. Neidhart and H. Ramuz, 1993, Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist, Nature 365, 759.
9. Clozel, M., V. Breu, G.A. Gray, B. Kalina, B-M. Loffler, K. Burri, J-M. Cassal, G. Hirth, M. Muller, W. Neidhart and H. Ramuz, 1994, Pharmacological characterisation of Bosentan, a new potent orally active non-peptide endothelin receptor antagonist, J. Pharmacol. Exp. Ther. 270, 228.
10. A) receptor selective antagonists, J. Med. Chem. 38, 1259.
11. Ekelund, U., 1994, In vivo effects of endothelin-2, endothelin-3 and ET(A) receptor blockade on arterial, venous and capillary functions in the cat skeletal muscle, Acta Physiol. Scand. 150, 147.
12. Ekelund, U., U. Albert, L. Edvinsson and S. Mellander, 1993, In vivo effects of endothelin-1 and ET(A) receptor blockade on arterial, venous and capillary functions in skeletal muscle, Acta Physiol. Scand. 148, 273.
13. Ekelund, U., M. Adner, L. Edvinsson and S. Mellander, 1995, Effects of the combined ET(A) and ET(B) receptor antagonist PD145065 on arteries, arterioles and veins in the cat hindlimb, J. Cardiovasc. Pharmacol. 26 (Suppl. 3), S211.
14. Ermisch, A., P. Brust, R. Kretzschmar and H.-J. Ruhle, 1993, Peptides and blood-brain barrier transport, Physiol. Revs. 73, 489.
15. Faraci, F. M., 1989, Effects of endothelin and vasopressin on cerebral blood vessels, Am. J. Physiol. 257, H799.
16. Feger, G.I., L. Schilling, H. Ehrenreich and M. Wahl, 1994, Endothelin-induced contraction and relaxation of rat isolated basilar artery: Effect of BQ-123, J. Cereb. Blood Flow Metab. 14, 845.
17. Fuxe, K., N. Kurosawa, A. Cintra, A. Hallstrom, M. Goiny, L. Rosen, L.F. Agnati and U. Ungerstedt, 1992, Involvement of local ischaemia in endothelin-1 induced lesions of the neostriatum of the anaesthetised rat, Exp. Brain Res. 88, 131.
18. Harper, A.M. and E.T. MacKenzie, 1977, Effects of 5-hydroxytryptamine on pial arteriolar calibre in anaesthetised cats, J. Physiol. 271, 735.
19. Haynes, W.G. and D.J. Webb, 1994, Contribution of endogenous generation of endothelin-1 to basal vascular tone, Lancet 344, 852.
20. Hollenberg, S.M., J.H. Shelhamer and R.E. Cunnion, 1993, Tachyphylaxis to the vasopressor effects of endothelin in rat aortic rings, Am. J. Physiol. 264, H352.
21. Homma, S., T. Miyauchi, Y. Sugishita, K. Goto, M. Sato and N. Ohshima, 1992, Vasoconstrictor effects of endothelin-1 on myocardium microcirculation studied by the Langendorff perfusion method: differential sensitivities among microvessels, Microvasc. Res. 43, 205.
22. A receptor, Life Sci. 50, 247.
23. 125I] BQ-3020 selective for endothelin ETB receptors, Life Sci. 51, PL47.
24. Jansen, I., B. Fallgren and L. Edvinsson, 1989, Mechanisms of actions of endothelin on isolated feline cerebral arteries: in vitro pharmacology and electrophysiology, J. Cereb. Blood Flow Metab. 9, 743.
25. C receptor) from Xenopus Laevis dermal melanocytes, J. Biol. Chem. 268, 29126.
26. Kitazono, T., D. Heistad and F.M. Faraci, 1993, Activation of endothelin B receptors produces dilatation of the basilar artery in vivo, Circulation 88, I-170.
27. Kobari, M., Y. Fukuuchi, M. Tomita, N. Tanahashi, S. Konno and H. Takeda, 1994a, Constriction/dilatation of the cerebral microvessels by intravascular endothelin-1 in cats, J. Cereb. Blood Flow Metab. 14, 64.
28. B receptor and nitric oxide in cats, Neurosci. Lett. 176, 157.
29. Kuschinsky, W. and M. Wahl, 1975, Alpha-receptor stimulation by endogenous and exogenous norepinephrine and blockade by phentolatnine in pial arteries of cats, Circ. Res. 37, 168.
30. Lüscher, T.F., 1993, Do we need endothelin antagonists?, Cardiovasc. Res. 27, 2089.
31. Macrae, I.M., M.J. Robinson, D.I. Graham, J.L. Reid and J. McCulloch, 1993, Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course and neuropathological consequences, J. Cereb. Blood Flow Metab. 13, 276.
32. Masaki, T., J.R. Vane and P.M. Vanhoutte, 1994, International Union of Pharmacology Nomenclature of Endothelin Receptors, Pharamcol. Rev. 46, 137.
33. McCulloch, J. and L. Edvinsson, 1980, Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide, Am. J. Physiol. 238, H449.
34. Patel, T.R., M.A. McAuley and J. McCulloch, 1994, Effects on feline pial arterioles in situ of bosentan, a non-peptide, endothelin receptor antagonist. Eur. J. Pharmacol. 260, 65.
35. Patel, T.R., S. Galbraith, M.A. McAuley and J. McCulloch, 1995a, Cerebrovascular significance of endothelin receptor antagonism in focal ischaemia, J. Cereb. Blood Flow Metab. 15 [Suppl. 1], S140.
36. Patel, T.R., M.A. McAuley, A.M. Doherty and J. McCulloch, 1995b, Pharmacological characterisation of peptide and non-peptide endothelin antagonists in cerebral arterioles in situ, J. Cereb. Blood Flow Metab. 15 [Suppl. 1], S537.
37. A) receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia, J. Cereb. Blood Flow Metab. (in press).
38. Robinson, M.J. and J. McCulloch, 1990, Contractile responses to endothelin in feline cortical vessels in situ, J. Cereb. Blood Flow Metab. 10, 285.
39. Rubanyi, G.M. and M.A. Polokoff, 1994, Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology, Pharmacol. Rev. 46, 325.
40. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto and T. Masaki, 1990, Cloning of cDNA encoding a non isopeptide selective subtype of the endothelin receptor, Nature 348, 732.
41. Salom, J., G. Torregrossa, M. Barbera, T. Jover and E. Alborch, 1993, Endothelin receptors mediating contraction in goat cerebral arteries, Br. J. Pharmacol. 109, 826.
42. B type endothelin receptor, J. Cereb. Blood Flow Metab. 15, 699.
43. A and endothelin ETB receptors mediate contraction to endothelin-1 in human blood vessels, Circulation 89, 1203.
44. Sharkey, J., I.M. Ritchie and P.A.T. Kelly, 1993, Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat, J. Cereb. Blood Flow Metab. 13, 865.
45. B receptor in vascular endothelium and smooth muscle, Biochem. Biophys. Res. Commun. 191, 459.
46. A receptor antagonist, J. Pharmacol. Exp. Ther. 264, 1040.
47. Spatz, M., D. Stanimirovic, A. Strasser and R. M. McCarron, 1995, Nitro-L-arginine augments endothelin-1 content of cerebrospinal fluid induced by cerebral ischaemia, Brain Res. 684, 99.
48. B receptor mediate vascular smooth muscle contraction, Br. J. Pharmacol. 107, 858.
49. Suzuki, R., H. Masaoka, Y. Hirata, F. Marumo, E. Isotani and K. Hirakawa, 1992, The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage, J. Neurosurg. 77, 96.
50. Warner, T.D., G.H. Allcock, R. Corder and J.R. Vane, 1993, Use of the endothelin antagonists BQ-123 and PD-142893 to reveal 3 endothelin receptors mediating smooth-muscle contraction and the release of EDRF, Br. J. Pharmacol. 110, 777.
51. Willette, R.N., C. Sauermelch, M. Ezekiel, G. Feuerstein and E.H. Ohlstein, 1990, Effect of endothelin on cortical microvascular perfusion in rats, Stroke 21, 451.
52. Willette, R.N., H. Zhang, M. P. Mitchell, C. F. Sauermelch, E.H. Ohlstein and A.C. Sulpizio, 1994, Nonpeptide endothelin antagonist: cerebrovascular characterisation and effects on delayed cerebral vasospasm, Stroke 25, 2450.
53. Yoshimoto, S., Y. Ishizaki, M. Kurihara, T. Sasaki, M. Yoshizumi, M. Yanagisawa, Y. Tazaki, T. Masaki, K. Takahura and S. Murota, 1990, Cerebral microvessel endothelium is producing endothelin, Brain Res. 580, 283.
54. Ziv, I., G. Heminger, R. Djaldetti, A. Achiron, E. Melamed and M. Sokolovsky, 1992, Increased plasma endothelin-1 in acute ischaemic stroke, Stroke 23, 1014.